HCA Holdings guidance appears conservative, says Wells Fargo After HCA increased its full-year EBITDA guidance, Wells Fargo thinks the revised guidance is probably too conservative. The firm raised its price target on the shares to $68-$78 from $52-$60. It keeps an Outperform rating on the shares.
HCA Holdings sees Q2 EPS about $1.18, consensus $1.32 Sees Q2 revenue $9.9B, consensus $9.77B. Q2 adjusted EBITDA is expected to be approximately $2.008B, compared to $2.0B in the previous year’s second quarter. Same facility admissions for Q2 increased 4.1%, while same facility equivalent admissions increased 4.9%. Same facility emergency room visits for Q2 increased 7.4% from the prior year’s second quarter. Same facility revenue per equivalent admission is expected to increase approximately 2.8% in Q2 compared to the prior year’s second quarter, after adjusting second quarter 2014 revenues to exclude the impact of the $142M adjustment to increase revenues related to the Texas Medicaid Waiver Program.